Ledger.Open graph →
SEC Form D · Amendment · filed December 30, 2019

Phoreus Biotechnology, Inc

Offering
$1.1M
Sold
$550K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OLATHE, KS
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joseph Pergolizzi · Naples, FLDirectorCindy Croissant · Poulsbo, WADirectorSteven Alecia · New York, NYDirectorNorman Leben · New York, NYDirectorHerman Cukier · Princeton, NJDirectorDavid Sze · San Francisco, CAExec · DirectorRandall Tosh · Olathe, KSExec · DirectorJoseph Petko · Princeton, NJExec · DirectorDaniel Motto · Princeton, NJExec · DirectorMatthew Tomich · New York, NYDirectorSteven Millner · New York, NYExec · DirectorGino Santini · Princeton, NJDirectorMichael Coe · Logan, UTExec · DirectorXiomara Sinisterra-Hunter · Port Saint Lucie, FLDirectorChristopher Brandt · Manhattan, KSDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗